Please assess the completion status of the following clinical trial:

Trial Title: A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 8.0

Eligibility Criteria:
Major Inclusion Criteria:~* Provision of written informed consent prior to any study-specific procedure~* Fasting LDL-C between 130 and 220 mg/dL following wash-out of all lipid regulating medications and supplements~* Fasting triglyceride \<400 mg/dL following wash-out of all lipid regulating medications and supplements~* BMI between 18 and 35 mg/kg2~Major Exclusion Criteria:~* Clinically significant cardiovascular disease, diabetes or uncontrolled hypertension~* Females of child bearing potential (i.e., females who are not surgically sterile or post-menopausal)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ETC-1002 120 mg (Group 1) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and normal triglycerides
- ETC-1002 80 mg (Group 2) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and normal triglycerides
- ETC-1002 40 mg (Group 3) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and normal triglycerides
- Placebo (Group 4) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and normal triglycerides
- ETC-1002 120 mg (Group 5) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and elevated triglycerides
- ETC-1002 80 mg (Group 6) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and elevated triglycerides
- ETC-1002 40 mg (Group 7) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and elevated triglycerides
- Placebo (Group 8) (Type: EXPERIMENTAL): Subjects with hypercholesterolemia and elevated triglycerides

Based on this trial design, predict the completion outcome and termination type (if applicable).